Dissociation of the renin lowering and antihypertensive actions of propranolol.

Advances in clinical pharmacology Pub Date : 1976-01-01
S Julius, M Esler, L Hansson, A J Zwiefler
{"title":"Dissociation of the renin lowering and antihypertensive actions of propranolol.","authors":"S Julius,&nbsp;M Esler,&nbsp;L Hansson,&nbsp;A J Zwiefler","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Suppression of renin release by beta-adrenoceptor blocking drugs has been advocated as the prime blood pressure lowering mechanism of these agents. The present report casts doubt on this proposition in three ways. In the first study, involving 22 patients with borderline hypertension, patients with elevated plasma renin levels showed normalization of the blood pressure after pharmacological autonomic blockade with intravenous atropine, propranolol and phentolamine, the time course of the pressure fall being such as to exclude suppression of renin release as the antihypertensive mechanism. It is clear that in patients with mild hypertension and high plasma renin levels, the elevation of blood pressure is maintained by a neurogenic mechanism, the elevated plasma renin having no direct role in sustaining the higher blood pressure. In two additional studies involving 21 patients in all with mild to moderately severe essential hypertension, to whom propranolol was administereed by mouth for 1--3 months, two findings were of interest:1) patients with low-renin essential hypertension showed a good antihypertensive response to propranolol, and 2) in some patients a dosedependent dissociation of the renin and blood pressure lowering action of propranolol could be demonstrated. These findings militate against the assumption that propranolol selectively lowers the blood pressure in \"renin-dependent\" hypertension, and strongly suggest that the antihypertensive action of this drug is not mediated by depression of plasma renin activity.</p>","PeriodicalId":75437,"journal":{"name":"Advances in clinical pharmacology","volume":"11 ","pages":"33-41"},"PeriodicalIF":0.0000,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in clinical pharmacology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Suppression of renin release by beta-adrenoceptor blocking drugs has been advocated as the prime blood pressure lowering mechanism of these agents. The present report casts doubt on this proposition in three ways. In the first study, involving 22 patients with borderline hypertension, patients with elevated plasma renin levels showed normalization of the blood pressure after pharmacological autonomic blockade with intravenous atropine, propranolol and phentolamine, the time course of the pressure fall being such as to exclude suppression of renin release as the antihypertensive mechanism. It is clear that in patients with mild hypertension and high plasma renin levels, the elevation of blood pressure is maintained by a neurogenic mechanism, the elevated plasma renin having no direct role in sustaining the higher blood pressure. In two additional studies involving 21 patients in all with mild to moderately severe essential hypertension, to whom propranolol was administereed by mouth for 1--3 months, two findings were of interest:1) patients with low-renin essential hypertension showed a good antihypertensive response to propranolol, and 2) in some patients a dosedependent dissociation of the renin and blood pressure lowering action of propranolol could be demonstrated. These findings militate against the assumption that propranolol selectively lowers the blood pressure in "renin-dependent" hypertension, and strongly suggest that the antihypertensive action of this drug is not mediated by depression of plasma renin activity.

心得安的解离降肾素和降压作用。
β -肾上腺素受体阻断药物抑制肾素释放被认为是这些药物降血压的主要机制。本报告从三个方面对这一主张提出质疑。在第一项研究中,22例交界性高血压患者,血浆肾素水平升高的患者经静脉阿托品、心得安和酚妥拉明药物自主神经阻断后血压恢复正常,血压下降的时间过程排除了抑制肾素释放的降压机制。显然,在轻度高血压和血浆肾素水平高的患者中,血压的升高是由神经源性机制维持的,血浆肾素的升高对维持较高的血压没有直接作用。在另外两项研究中,21例轻度至中度原发性高血压患者口服心得安1- 3个月,两项研究结果令人感兴趣:1)低肾素原发性高血压患者对心得安表现出良好的降压反应;2)在一些患者中,可以证明心得安对肾素和降压作用的剂量依赖性解离。这些发现否定了普萘洛尔选择性降低“肾素依赖性”高血压患者血压的假设,并强烈提示该药物的降压作用不是通过抑制血浆肾素活性介导的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信